Text size Daniel Acker / Bloomberg Shares of the large pharmaceutical company Pfizer continue to rise one day after the company revealed promising and detailed data on a trial of its experimental vaccine Covid-19. Analysts said the highly aggressive timeline the company outlined on Wednesday was exciting, but far from …
Read More »Hydroxychloroquine COVID-19 Global Prevention Trial to Resume
LONDON (Reuters) – A global trial designed to test whether antimalarial drugs hydroxychloroquine and chloroquine can prevent COVID-19 infection, will restart after being approved by British regulators. FILE PHOTO: A pharmacist shows a box of hydroxychloroquine at CHR Center Hospitalier Regional de la Citadelle amid coronavirus disease (COVID-19) in Liège, …
Read More »Intercept actions fall on NASH disappointment
Text size Dirk Waem / Getty Images NASH was once the next big thing for big drug companies; a newly defined disorder that requires chronic treatment that affects millions of people in developed countries. Dozens of companies are developing drugs for the disease, which can cause life-threatening conditions like decompensated …
Read More »Moderna is the latest partner in the coronavirus vaccine for Catalent
Text size Joseph Prezioso / AFP via Getty Images Moderna said it has partnered with Catalent to make the Covid-19 vaccine that the biotech company is about to test in the country’s first major clinical trial. Although the vaccine’s large-scale safety and efficacy have not yet been proven, the urgency …
Read More »The demand of EE. USA Exceeds supply of steroid treatment for COVID
FILE PHOTO: A blister of dexamethasone is seen during the outbreak of coronavirus disease (COVID-19) in this image illustration taken on June 17, 2020. REUTERS / Yves Herman / File Photo NEW YORK (Reuters) – Increasing hospital demand for steroid dexamethasone, which British researchers say significantly reduces mortality among seriously …
Read More »